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Previewsthe intramolecular NBS/CBS interaction,
which potentiates the pathogenic scaf-
fold/hub function of CagA.
Finally, the authors investigated CagA-
phosphatidylserine (PS) interactions, as
this influences the transport of CagA and
its localization to the inner plasma mem-
brane (Murata-Kamiya et al., 2010). Two
arginines (R624 and R626), crucial for
the CagA-PS interaction, were located in
the a18 helix of Domain-II. Structural
and mutational analyses identified that
R624 and R626 form a basic amino acid
cluster with several lysine residues (posi-
tion 613, 614, 617, 621, 625, 631, and
635), providing a positive electrostatic
surface potential important for CagA-PS
docking. The molecular orientation of
delivered CagA relative to the plasma
membrane was also deduced from these
studies.
Taken together, the above findings pro-
vide a comprehensive structural picture of
the N terminus of CagA. The tertiary struc-
ture of CagA1-876 is unique, with no
homologous other structure yet reported.
Structure-function data reported here
clearly indicate that the N terminus mayserve as a regulatory element for the
C terminus. However, the current
CagA1-876 structure still has gaps due to
resolution problems. Thus, more efforts
are necessary to obtain high-resolution
crystal structures of the N and C terminus
and CagAFL. It will be also highly inter-
esting to investigate in future studies
how other known interaction partners in-
cluding RUNX3, integrin-b1, apoptosis-
stimulating protein of p53 (ASPP2),
CagF, and others interact with the indi-
vidual segments of CagA1-876 and influ-
ence its function. Efforts to cocrystallize
CagA with these or other interaction part-
ners may be helpful here. The present
studies of Hayashi et al. (2012) provide
important knowledge for the under-
standing of H. pylori-triggered pathology
and developing inhibitors for more effec-
tive new therapy against this important
pathogen.REFERENCES
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Neutrophil extracellular traps (NETs) are comprised of extracellular DNA coated in cytotoxic proteins capable
of ensnaring and killing bacteria. Saitoh et al. (2012) expand our understanding of NETs into antiviral immunity
by demonstrating that HIV induces the formation of NETs, which can bind and neutralize viral particles.Neutrophils are the foot soldiers of the
innate immune response. These cells are
often the first to respond to pathogens,
arriving rapidly and deploying a vast array
of antimicrobial agents in an effort to
control the early phases of infection. This
arsenal of effector mechanisms include
the ability to phagocytose pathogens
and the release of large numbers of anti-microbial peptides, cytokines, and reac-
tive oxygen species (ROS). More recently,
a novel effector mechanism has been
described whereby in response to a path-
ogen, the nuclear DNA of the neutrophil
decondenses and is released from the
cell to form a large sticky web. These
Neutrophil extracellular traps (NETs) are
decorated with histones—and antimicro-bial proteins such as neutrophil elastase,
myeloperoxidase (MPO), and a-defensin
(Brinkmann et al., 2004). Furthermore,
NETs have been demonstrated to both
ensnare and directly kill a number of
different bacteria.
Although viral infection has classically
been studied in the context of the
adaptive immune response, a significantbe 12, July 19, 2012 ª2012 Elsevier Inc. 5
Figure 1. Interactions between HIV, Neutrophils, DC, and NETs
Upon detection of HIV through either TLR7 or TLR8, neutrophils initiate ROS
generation. The production of ROS results in the decondensation of the
neutrophil nucleus and the eventual release of NETs. NETs are capable of en-
snaring HIV virions and, through the action of granular proteins bound to the
DNA strands, neutralizing the viral particles. HIV is not simply the target of
this innate immune response but rather actively modulates the process. Viral
binding to CD209 on DC results in the production of IL-10 by the DC. IL-10
modulates neutrophil function, reducing ROS production and attenuating
NET release.
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Previewsamount of evidence exists to
suggest a critical role for the
innate immune system in
the host antiviral immune
response. The innate immune
system detects viral path-
ogen-associated molecular
patterns (PAMPs) through a
diverse array of pattern re-
cognition receptors (PRR),
including Toll-like receptor
(TLR)-3, 7, and 8, as well
as RIG-I and MDA5, sug-
gesting the evolution of
an antiviral response within
this arm of the immune
system. Furthermore, neutro-
phils themselves have been
demonstrated to be essential
for the early control of highly
pathogenic influenza infec-
tions; however, the specific
mechanisms involved in this
antiviral response remained
unclear (Tate et al., 2009).
In this issue, Saitoh et al.
(2012) link the production of
NETs by human neutrophils,previously thought of as an antibacterial
effector mechanism, to the host antiviral
response. In a series of elegant experi-
ments, Saitoh et al. (2012) are able to
demonstrate that neutrophils release
NETs in response to exposure to HIV
virions alone, and that these extracellular
DNA structures are able to bind and,
more importantly, directly inactivate the
HIV virus. This viral neutralization was
dependent on the presence of MPO and
a-defensin within the NET structure, as
destruction of NETswith DNase, inhibition
of MPO, or blocking antibodies against
a-defensin abrogated the ability of the
neutrophils to neutralize HIV. Using
superresolution structured illumination
microscopy (SR-SIM), Saitoh et al. (2012)
were able to capture striking 3D images
of NETs at a much higher resolution
than is possible with conventional fluo-
rescence microscopy. The images reveal
sheets of DNA rather than the previously
reported strands or strings. Moreover,
these studies clearly illustrate the intri-
cacy of the extracellular DNA structures
and directly visualize the capture of intact
virus particles by NETs.
Through the use of a series of chemical
and protein inhibitors, Saitoh et al. (2012)
further demonstrate the ability of HIV to6 Cell Host & Microbe 12, July 19, 2012 ª201induce NET production by neutrophils is
dependent on TLR-7, TLR-8, and the
generation of ROS (Figure 1). These find-
ings are particularly interesting, as the
initiation of NET release by bacteria or
bacterial ligands is also dependent on
ROS production (Fuchs et al., 2007).
These findings suggest that regardless
of the specific nature of the pathogen
(bacterial versus viral), stimulation of
neutrophils through one of a number of
different PRR can result in the activation
of a common innate effector response,
culminating in the dissolution of the
neutrophil’s nuclei and the release of
NETs in an effort to ensnare and neu-
tralize the invading pathogen. It remains
unclear from this study whether this
NET production actually led to neutrophil
death or whether neutrophils maintained
viability and helped to eliminate NET
caught pathogens.
This interaction between the neutrophil
and the virus is not a one-way street
whereby the neutrophil simply reacts
to the pathogen but rather a complex
and dynamic relationship in which the
pathogen attempts to modulate the neu-
trophil’s response. As with most host-
effector processes, pathogens have
evolved strategies and mechanisms to2 Elsevier Inc.escape NETs. The best char-
acterized of these strategies
is the production of nucleases
by some bacterial strains to
digest NET structures (Bu-
chanan et al., 2006). The
expression of these nucle-
ases contributes to bacterial
virulence and facilitates the
evasion of the host innate
immune response.
Importantly, in the current
study the authors also identi-
fied a means by which HIV is
able to regulate NET produc-
tion by neutrophils; however,
rather than targeting the
neutrophil or NETs directly,
HIV modulates the local
immune microenvironment.
Saitoh et al. (2012) demon-
strate that HIV is able to bind
to the surface of dendritic
cells (DC) via CD209 (DC-
SIGN), a C-type lectin re-
ceptor, and induce the pro-
duction of IL-10, a potent
anti-inflammatory cytokine.Treatment of activated neutrophils with
supernatants from HIV-treated DC or
with purified IL-10 attenuated NET pro-
duction and significantly reduced the
virucidal capacity of human neutrophils.
It is important to note that these studies
were carried out using an in vitro cell-
culture system. Although the work by
Saitoh et al. (2012) beautifully charac-
terize the antiviral potential of NETs and
the complex dynamic that exists between
HIV, DC, and neutrophils, it will be impor-
tant to understand how these mecha-
nisms function within the context of the
host immune response to viruses in vivo.
The authors propose that this interaction
could occur in the mucosa, but one could
also imagine NETs being formed in blood
as was reported by Clark et al. (2007). In
fact, trying to catch viruses under flow
conditions could be quite difficult, but
the release of NETs could facilitate the
capture of many viral particles by a single
cell. Moreover, the efficacy of this novel
antiviral response is dependent on the
ability of neutrophils to deploy their
NETs in such a manner that they are
able to ensnare free virus. This mecha-
nism has great potential in limiting viral
dissemination but may be of limited value
in dealing with virally infected host cells.
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PreviewsFurthermore, as indicated by the authors,
some viral infections induce neutropenia
and, as such, these viruses may be able
to limit the antiviral potential of the neutro-
phil response.
Regardless of the potential complex-
ities of the in vivo response, the study by
Saitoh et al. (2012) represents a de facto
antiviral response and, as suggested by
the authors, also represents an exciting
opportunity for the development of new
therapeutic approaches to viral infec-
tions. Strategies targeting neutrophils,
and specifically the generation of NETs,
may prove to be important tools in limiting
viral replication and spread. However, one
must be cautious in developing NETs
as an antiviral therapy. NETs, like most
immune effector mechanisms, are only
effective if they are a component of a
balanced response. Recent studies have
indicated excess NET formation can
result in host tissue damage and may
be associated with a number of human
disease states (Clark et al., 2007; Nara-
saraju et al., 2011; Thomas et al., 2012;
Leffler et al., 2012). Future immunother-apies directed at controlling viral infec-
tions through the generation of NETs will
have to strike a balance between viral
neutralization and host tissue damage.
These findings by Saitoh et al. (2012)
open an entirely new chapter in our under-
standing of the innate immune response
to viruses and blur the lines between anti-
viral and antimicrobial immunity. Further-
more, this study represents a unique
opportunity for the development of anti-
viral therapies, particularly when viral
infections are found in the context of
neutrophilic inflammation.ACKNOWLEDGMENTS
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